Veradigm Cash on Hand 2010-2022 | MDRX
Veradigm cash on hand from 2010 to 2022. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Veradigm Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2022 | $448 |
| 2021 | $135 |
| 2020 | $537 |
| 2019 | $138 |
| 2018 | $185 |
| 2017 | $131 |
| 2016 | $97 |
| 2015 | $117 |
| 2014 | $53 |
| 2013 | $63 |
| 2012 | $104 |
| 2011 | $158 |
| 2010 | $132 |
| 2010 | $143 |
| 2009 | $71 |
| Veradigm Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2022-12-31 | $448 |
| 2022-09-30 | $494 |
| 2022-06-30 | $501 |
| 2022-03-31 | $84 |
| 2021-12-31 | $135 |
| 2021-09-30 | $216 |
| 2021-06-30 | $231 |
| 2021-03-31 | $516 |
| 2020-12-31 | $537 |
| 2020-09-30 | $225 |
| 2020-06-30 | $205 |
| 2020-03-31 | $212 |
| 2019-12-31 | $138 |
| 2019-09-30 | $139 |
| 2019-06-30 | $148 |
| 2019-03-31 | $148 |
| 2018-12-31 | $185 |
| 2018-09-30 | $120 |
| 2018-06-30 | $141 |
| 2018-03-31 | $144 |
| 2017-12-31 | $131 |
| 2017-09-30 | $109 |
| 2017-06-30 | $89 |
| 2017-03-31 | $104 |
| 2016-12-31 | $97 |
| 2016-09-30 | $77 |
| 2016-06-30 | $91 |
| 2016-03-31 | $100 |
| 2015-12-31 | $117 |
| 2015-09-30 | $91 |
| 2015-06-30 | $77 |
| 2015-03-31 | $88 |
| 2014-12-31 | $53 |
| 2014-09-30 | $37 |
| 2014-06-30 | $39 |
| 2014-03-31 | $42 |
| 2013-12-31 | $63 |
| 2013-09-30 | $61 |
| 2013-06-30 | $72 |
| 2013-03-31 | $92 |
| 2012-12-31 | $104 |
| 2012-09-30 | $94 |
| 2012-06-30 | $120 |
| 2012-03-31 | $176 |
| 2011-12-31 | $158 |
| 2011-09-30 | $85 |
| 2011-06-30 | $116 |
| 2011-03-31 | $145 |
| 2010-12-31 | $132 |
| 2010-09-30 | $122 |
| 2010-06-30 | |
| 2010-05-31 | $143 |
| 2010-03-31 | |
| 2010-02-28 | $116 |
| 2009-12-31 | $81 |
| 2009-11-30 | $89 |
| 2009-09-30 | |
| 2009-08-31 | $85 |
| 2009-05-31 | $71 |
| 2009-02-28 | $75 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.503B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.457B | 60.38 |
| Hims & Hers Health (HIMS) | United States | $12.904B | 134.07 |
| Doximity (DOCS) | United States | $11.414B | 52.84 |
| Tempus AI (TEM) | United States | $11.164B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.284B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.801B | 59.38 |
| Hinge Health (HNGE) | United States | $3.571B | 0.00 |
| Privia Health (PRVA) | United States | $2.402B | 164.21 |
| 10x Genomics (TXG) | United States | $1.737B | 0.00 |
| Schrodinger (SDGR) | United States | $1.631B | 0.00 |
| Phreesia (PHR) | United States | $1.585B | 0.00 |
| Azenta (AZTA) | United States | $1.576B | 73.25 |
| Enovis (ENOV) | United States | $1.573B | 8.77 |
| Clover Health Investments (CLOV) | United States | $1.545B | 0.00 |
| Omnicell (OMCL) | United States | $1.324B | 23.36 |
| Evolent Health (EVH) | United States | $1.166B | 99.30 |
| Claritev (CTEV) | United States | $0.652B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.559B | 0.00 |
| Standard BioTools (LAB) | United States | $0.532B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.487B | 0.00 |
| Talkspace (TALK) | United States | $0.421B | 125.75 |
| TruBridge (TBRG) | United States | $0.353B | 783.33 |
| Outset Medical (OM) | United States | $0.328B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.258B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.240B | 0.00 |
| CapsoVision (CV) | United States | $0.185B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.161B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.160B | 0.00 |
| American Well (AMWL) | United States | $0.140B | 0.00 |
| Pulmonx (LUNG) | United States | $0.134B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.118B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.118B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 3.95 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.099B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.083B | 0.00 |
| 111 (YI) | China | $0.063B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |